Market Research Reports and Industry Reports

Europe Radioimmunoassay Market By Type (Reagents & Kits, Analyzers), by Application (Research, Clinical Diagnostics), by End User (Hospital, Pharmaceuticals Industry & CRO, Academics, Clinical Diagnostic Laboratories, Others), & By Geography-Analysis & Forecast to 2020

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The research report categorizes the Europe radioimmunoassay (RIA) market by type into two segments: analyzers and reagents & kits. Based on application, the market has been segmented into research and clinical diagnostics, providing exhaustive value analysis for 2014 as well as forecast up to 2020. The end users include hospitals, clinical diagnostics labs, academics, pharmaceutical industry and CRO, & others. The market is comprehensively analyzed at a granular level based on geography, into Germany, France, U.K., Italy, Spain, and Rest of the Europe to provide in-depth information.

The technique of radioimmunoassay (RIA) is advanced and sensitive enough to find small molecules in the blood, and is therefore used for research purposes and diagnosis of diseases, such as cancer. This technique is also implemented by organizations and research labs for research purposes using serum from animals or humans. The new range of immunoassay kits and analyzers provide remedies for autoimmune diseases, such as diabetes. These are widely used in the process of drug discovery and screening in blood banks.

Radioimmunoassay (RIA) is one of the pivotal and traditional methods used for the testing of endocrinological disorders. RIA also has prominent usage in the field of neurodegenerative disorders. In spite of the high precision, robust nature, and impeccable sensitivity, the global radioimmunoassay (RIA) market has been witnessing a slow growth in terms of market values and kit volumes. This can be attributed to the paradigm shift in the adoption of alternatives, such as, ELISA, chemiluminescence assay, immunofluorescence assay, & other non-radio techniques and lack of automation.

In Europe, many clinical laboratories are taking measures to remove RIA tests off their shelf; ELISA has been instrumental in taking over the RIA tests. European Greens has been instrumental in maintaining environmental responsibility across geographies. The utilization of radioactive substances in RIA procedures poses a threat to environment and human health. Thus, the political scenario has negatively impacted the use of RIA tests in Europe due to the conscious effort from the European Greens. In spite of the above-mentioned dynamics, Europe captures a major market share in RIA globally. Majority of the RIA manufacturers are based out of Europe, thus claiming a strong footprint in Europe.

In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. The major players in the radioimmunoassay are IBL International (A Tecan Company) (Germany), Cisbio (France), DiaSorin S.p.A. (Italy), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), Euro Diagnostica AB (Sweden), DIAsource ImmunoAssays SA (Belgium), PerkinElmer, Inc. (U.S.), MP Biomedicals, LLC (U.S.), DRG International, Inc. (U.S.), & Beckman Coulter, Inc. (U.S.).

1 INTRODUCTION 11
 1.1 OBJECTIVES OF THE STUDY 11
 1.2 MARKET SEGMENTATION & COVERAGE 12
 1.3 STAKEHOLDERS 12
 2 RESEARCH METHODOLOGY 13
 2.1 INTEGRATED ECOSYSTEM OF THE RADIOIMMUNOASSAY (RIA) MARKET 14
 2.2 ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE 15
 2.2.1 TOP-DOWN APPROACH 16
 2.2.2 MACRO INDICATOR-BASED APPROACH 17
 2.3 ASSUMPTIONS 18
 3 EXECUTIVE SUMMARY 19
 4 MARKET OVERVIEW 22
 4.1 INTRODUCTION 22
 4.2 RADIOIMMUASSAY (RIA) MARKET: COMPARISON WITH PARENT MARKET 23
 4.3 MARKET DRIVERS AND INHIBITORS 25
 5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE 26
 5.1 INTRODUCTION 27
 5.2 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET 29
 5.3 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET 30
 6 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER 32
 6.1 INTRODUCTION 33
 6.2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS 35
 6.3 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY
 AND CRO 37
 6.4 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS 38
 6.5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES 40
 7 RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION 42
 7.1 INTRODUCTION 43
 7.2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY 45
 7.3 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS,
 BY GEOGRAPHY 46
 7.4 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION 47
 7.5 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY 48
 7.6 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY 49
 7.7 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY 50
 8 EUROPE RADIOIMMUNOASSAY MARKET, BY GEOGRAPHY 51
 8.1 INTRODUCTION 52
 8.1.1 GERMANY RADIOIMMUNOASSAY (RIA) MARKET 53
 8.1.2 FRANCE RADIOIMMUNOASSAY (RIA) MARKET 54
 8.1.3 U.K. RADIOIMMUNOASSAY (RIA) MARKET 56
 8.1.4 ITALY RADIOIMMUNOASSAY (RIA) MARKET 57
 8.1.5 SPAIN RADIOIMMUNOASSAY (RIA) MARKET 58
 9 EUROPE RADIOIMMUNOASSAY MARKET: COMPETITIVE LANDSCAPE 60
 9.1 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COMPANY SHARE ANALYSIS 60
 10 EUROPE RADIOIMMUNOASSAY MARKET, BY COMPANY 65
 10.1 DIASORIN S.P.A. 65
 10.1.1 OVERVIEW 65
 10.1.2 FINANCIALS 66
 10.1.3 PRODUCTS AND SERVICE OFFERINGS 66
 10.1.4 RECENT DEVELOPMENT 67
 10.1.5 MMM VIEW 68
 10.2 EURO DIAGNOSTICA AB 69
 10.2.1 OVERVIEW 69
 10.2.2 FINANCIALS 69
 10.2.3 PRODUCTS AND SERVICE OFFERINGS 69
 10.2.4 RECENT DEVELOPMENT 70
 10.2.5 MMM VIEW 70
 10.3 MERCK MILLIPORE CORPORATION 71
 10.3.1 OVERVIEW 71
 10.3.2 FINANCIALS 71
 10.3.3 PRODUCTS AND SERVICE OFFERINGS 72
 10.3.4 RECENT DEVELOPMENT 72
 10.3.5 MMM VIEW 73
 10.4 DIASOURCE IMMUNOSSAYS S.A 74
 10.4.1 OVERVIEW 74
 10.4.2 FINANCIALS 74
 10.4.3 PRODUCTS AND SERVICE OFFERINGS 74
 10.4.4 RECENT DEVELOPMENT 75
 10.4.5 MMM VIEW 75
 10.5 STRATEC BIOMEDICALS AG 76
 10.5.1 OVERVIEW 76
 10.5.2 KEY FINANCIALS 76
 10.5.3 PRODUCT AND SERVICE OFFERINGS 77
 10.5.4 RELATED DEVELOPMENTS 77
 10.5.5 MMM VIEW 77
 10.6 BERTHOLD TECHNOLOGIES GMBH & CO. KG 78
 10.6.1 OVERVIEW 78
 10.6.2 KEY FINANCIALS 78
 10.6.3 PRODUCT AND SERVICE OFFERINGS 78
 10.6.4 RELATED DEVELOPMENTS 79
 10.4. MMM VIEW 79
 10.7 IZOTOP 80
 10.7.1 OVERVIEW 80
 10.7.2 KEY FINANCIALS 80
 10.7.3 PRODUCT AND SERVICE OFFERINGS 80
 10.7.4 RELATED DEVELOPMENTS 82
 10.7.5 MMM VIEW 82
 10.8 BECKMAN COULTER, INC. 83
 10.8.1 OVERVIEW 83
 10.8.2 KEY FINANCIALS 83
 10.8.3 PRODUCT AND SERVICE OFFERINGS 84
 10.8.4 RELATED DEVELOPMENTS 84
 10.8.5 MMM ANALYSIS 84
 10.9 CISBIO 85
 10.9.1 OVERVIEW 85
 10.9.2 KEY FINANCIALS 85
 10.9.3 PRODUCT AND SERVICE OFFERINGS 85
 10.9.4 RELATED DEVELOPMENTS 86
 10.9.5 MMM VIEW 87
 10.10 MP BIOMEDICALS LLC 88
 10.10.1 OVERVIEW 88
 10.10.2 KEY FINANCIALS 88
 10.10.3 PRODUCT AND SERVICE OFFERINGS 88
 10.10.4 RELATED DEVELOPMENTS 89
 10.10.5 MMM VIEW 90
 10.11 PERKINELMER, INC. 91
 10.11.1 OVERVIEW 91
 10.11.2 KEY FINANCIALS 91
 10.11.3 PRODUCT AND SERVICE OFFERINGS 92
 10.11.4 RELATED DEVELOPMENTS 92
 10.11.5 MMM VIEW 92
 10.12 IBL INTERNATIONAL (A TECAN COMPANY) 93
 10.12.1 OVERVIEW 93
 10.12.2 KEY FINANCIALS 94
 10.12.3 PRODUCT AND SERVICE OFFERINGS 94
 10.12.4 RELATED DEVELOPMENTS 95
 10.12.5 MMM VIEW 95
 10.13 DRG INTERNATIONAL, INC. 96
 10.13.1 OVERVIEW 96
 10.13.2 KEY FINANCIALS 96
 10.13.3 PRODUCT AND SERVICE OFFERINGS 96
 10.13.4 RELATED DEVELOPMENTS 98
 10.13.5 MMM VIEW 98
 11 APPENDIX 99
 11.1 CUSTOMIZATION OPTIONS 99
 11.1.1 PRODUCT ANALYSIS 99
 11.1.2 BRAND/PRODUCT PERCEPTION MATRIX 99
 11.1.3 PORTER’S FIVE FORCES ANALYSIS 99
 11.2 RELATED REPORTS 100
 11.3 RT SNAPSHOT 100


List Of Tables

TABLE 1 GLOBAL IMMUNOASSAY MARKET SIZE & RADIOIMMUNOASSAY MARKET SIZE,
 2014 (USD MILLION) 18
 TABLE 2 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COMPARISON WITH PARENT MARKET, 2013–2020 (USD MILLION) 23
 TABLE 3 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY,
 2013-2020 (USD MILLION) 24
 TABLE 4 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS AND KITS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION) 25
 TABLE 5 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: DRIVERS AND INHIBITORS 25
 TABLE 6 EUROPE RADIOIMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION) 28
 TABLE 7 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION) 30
 TABLE 8 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY,
 2013–2020 (USD MILLION) 31
 TABLE 9 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END-USERS,
 2013–2020 (USD MILLION) 34
 TABLE 10 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN HOSPITALS, BY GEOGRAPHY,
 2013–2020 (USD MILLION) 36
 TABLE 11 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY
 AND CRO, BY GEOGRAPHY, 2013–2020 (USD MILLION) 37
 TABLE 12 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY,
 2013–2020 (USD MILLION) 39
 TABLE 13 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013–2020 (USD MILLION) 41
 TABLE 14 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION,
 2013-2020 (USD MILLION) 44
 TABLE 15 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY,
 2013-2020 (USD MILLION) 45
 TABLE 16 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS,
 BY GEOGRAPHY, 2013-2020 (USD MILLION) 46
 TABLE 17 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION) 47
 TABLE 18 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION) 48
 TABLE 19 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION) 49
 TABLE 20 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION) 50
 TABLE 21 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY,
 2014 & 2020 (USD MILLION) 53
 TABLE 22 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION) 53
 TABLE 23 GERMANY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION,
 2013-2020 (USD MILLION) 54
 TABLE 24 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION) 55
 TABLE 25 FRANCE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION,
 2013-2020 (USD MILLION) 55
 TABLE 26 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION) 56
 TABLE 27 U.K. RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 56
 TABLE 28 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION) 57
 TABLE 29 ITALY RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION,
 2013-2020 (USD MILLION) 57
 TABLE 30 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013-2020 (USD MILLION) 58
 TABLE 31 SPAIN RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION,
 2013-2020 (USD MILLION) 59
 TABLE 32 EUROPE RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS,
 2014 (%) 61
 TABLE 33 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 62
 TABLE 34 DIASORIN S.P.A, REVENUE, 2010-2014 (USD MN) 66
 TABLE 35 MERCK MILLIPORE CORPORATION, KEY FINANCIALS, 2010-2014 (USD MN) 72


List Of Figures

FIGURE 1 EUROPE RADIOIMMUNOASSAY (RIA) MARKET SEGMENTATION & COVERAGE 12
 FIGURE 2 RADIOIMMUNOASSAY (RIA) MARKET: INTEGRATED ECOSYSTEM 14
 FIGURE 3 ARRIVING AT THE RADIOIMMUNOASSAY (RIA) MARKET SIZE 15
 FIGURE 4 TOP-DOWN APPROACH 16
 FIGURE 5 MACRO INDICATOR-BASED APPROACH 17
 FIGURE 6 EUROPE RADIOIMMUNOASSAY (RIA) MARKET SNAPSHOT, 2014 21
 FIGURE 7 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, COMPARISON WITH PARENT MARKET, 2013-2020 (USD MILLION) 23
 FIGURE 8 EUROPE RADIOIMMUNOASSAY (RIA) TYPE MARKET, BY GEOGRAPHY,
 2014 (USD MILLION) 24
 FIGURE 9 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY TYPE, 2013–2020 (USD MILLION) 28
 FIGURE 10 EUROPE RADIOIMMUNOASSAY (RIA) REAGENTS & KITS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION) 29
 FIGURE 11 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET, BY GEOGRAPHY,
 2013–2020 (USD MILLION) 31
 FIGURE 12 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY END USER, 2013–2020 (USD MILLION) 33
 FIGURE 13 EUROPE RADIOIMMUNOASSAY (RIA) HOSPITALS MARKET, BY GEOGRAPHY,
 2013–2020 (USD MILLION) 35
 FIGURE 14 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN PHARMACEUTICAL INDUSTRY AND CRO, BY GEOGRAPHY, 2013–2020 (USD MILLION) 37
 FIGURE 15 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN ACADEMICS, BY GEOGRAPHY,
 2013–2020 (USD MILLION) 38
 FIGURE 16 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2013–2020 (USD MILLION) 40
 FIGURE 17 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY APPLICATION,
 2013-2020 (USD MILLION) 44
 FIGURE 18 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN RESEARCH, BY GEOGRAPHY,
 2013-2020 (USD MILLION) 45
 FIGURE 19 EUROPE RADIOIMMUNOASSAY (RIA) MARKET IN CLINICAL DIAGNOSTICS,
 BY GEOGRAPHY, 2013-2020 (USD MILLION) 46
 FIGURE 20 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION) 47
 FIGURE 21 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION) 48
 FIGURE 22 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN RESEARCH APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION) 49
 FIGURE 23 EUROPE RADIOIMMUNOASSAY (RIA) KITS & REAGENTS MARKET IN CLINICAL DIAGNOSTICS APPLICATION, BY GEOGRAPHY, 2013-2020 (USD MILLION) 50
 FIGURE 24 EUROPE RADIOIMMUNOASSAY (RIA) MARKET, BY GEOGRAPHY, 2014 & 2020 52
 FIGURE 25 GERMANY RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%) 53
 FIGURE 26 FRANCE RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW, 2014 & 2020 (%) 54
 FIGURE 27 U.K. RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW, 2014 & 2020 (%) 56
 FIGURE 28 ITALY RADIOIMMUNOASSAY (RIA) MARKET, OVERVIEW 2014 & 2020 (%) 57
 FIGURE 29 SPAIN RADIOIMMUNOASSAY (RIA) MARKET OVERVIEW 2014 & 2020 (%) 58
 FIGURE 30 EUROPE RADIOIMMUNOASSAY (RIA) KITS MARKET: COMPANY SHARE ANALYSIS,
 2014 (%) 60
 FIGURE 31 EUROPE RADIOIMMUNOASSAY (RIA) ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 62
 FIGURE 32 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: KEY PLAYERS OPERATING IN APPLICATION AREAS 63
 FIGURE 33 EUROPE RADIOIMMUNOASSAY (RIA) MARKET: COVERAGE OF KEY PLAYERS
 BY APPLICATION 64
 FIGURE 34 DIASORIN S.P.A: GEOGRAPHICAL AND BUSINESS REVENUE MIX 2014(%) 65
 FIGURE 35 DIASORIN S.P.A, REVENUE MIX, 2010-2014 (USD MN) 66
 FIGURE 36 MERCK MILLIPORE CORPORATION, KEY FINANCIALS, 2010-2014 (USD MN) 71
 FIGURE 37 STRATEC BIOMEDICAL AG, REVENUE MIX, 2010-2014 (USD MN) 76
 FIGURE 38 STRATEC BIOMEDICAL AG, REVENUE MIX, 2010-2014 (USD MN) 76
 FIGURE 39 DANAHER CORPORATIONS: REVENUE MIX, 2014 (%) 83
 FIGURE 40 PERKINELMER, INC.: REVENUE MIX, 2014 (%) 91
 FIGURE 41 TECAN TRADING AG: REVENUE MIX, 2014 (%) 93


Europe Laboratory Reagent Dispenser Market Report 2016

Notes:Sales, means the sales volume of Laboratory Reagent DispenserRevenue, means the sales value of Laboratory Reagent DispenserThis report studies sales (consumption) of Laboratory Reagent Dispenser in Europe market, especially in

USD 3900View Report

Europe Glimepiride Market Report 2016

Notes:Sales, means the sales volume of GlimepirideRevenue, means the sales value of GlimepirideThis report studies sales (consumption) of Glimepiride in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux

USD 3900View Report

Europe Garden Sprayers Market Report 2016

Notes:Sales, means the sales volume of Garden SprayersRevenue, means the sales value of Garden SprayersThis report studies sales (consumption) of Garden Sprayers in Europe market, especially in Germany, UK, France,

USD 3900View Report

Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020

Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), by Application (Research, Clinical Diagnostics), by End User (Hospitals, Pharmaceutical Industry & CROs, Academics, Others), by Geography– Global Forecast to 2020

USD 4650View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 2650
  • Multi User Licence    $ 3250
  • Corporate Licence    $ 4505
  • Enterprise Wide Licence    $ 5150
$ 2650

Reports Details

Published Date : Oct 2015
No. of Pages :101
Country :Europe
Category :Healthcare
Publisher :Micro Market Monitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment